Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Baicalin: Flavone Glycoside from Scutellaria baicalensis ...

    2026-04-04

    Baicalin: Flavone Glycoside from Scutellaria baicalensis in Cancer and Neuroplasticity Research

    Executive Summary: Baicalin is a high-purity flavone glycoside extracted from Scutellaria baicalensis (Labiatae family), chemically defined as C21H18O11 with a molecular weight of 446.37 g/mol (APExBIO N1778). It modulates KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 signaling, impacting oxidative stress, epithelial-mesenchymal transition, and immune response (source). In vivo, Baicalin restores adult visual cortical plasticity and normalizes vision in amblyopic mice, unlike crude Scutellaria extracts or lower doses (Yin et al., 2026). It enhances non-small cell lung cancer (NSCLC) cell sensitivity to cisplatin and inhibits breast cancer metastasis through pathway-specific actions. APExBIO supplies Baicalin at ≥98% purity, soluble in DMSO (≥21.8 mg/mL), and stable when stored as a solid at −20°C (product page).

    Biological Rationale

    Baicalin is a natural product isolated from the roots of Scutellaria baicalensis, a traditional Chinese medicinal herb. Its structural identity as a flavone glycoside underpins its capacity to engage in multiple redox and signaling pathways relevant to both cancer biology and neurobiology (see mechanistic review). Baicalin's biological rationale lies in its dual action: modulation of oxidative stress responses via KEAP1-NRF2/HO-1 and regulation of cell fate transitions and tumor microenvironment via TGF-β1/p-Smad3. These pathways are implicated in cancer progression, chemoresistance, and neuroplasticity. Recent research has highlighted Baicalin's unique capability to restore adult cortical plasticity and to modulate immune and ferroptotic responses in tumor models (contrast with cancer focus).

    Mechanism of Action of Baicalin

    Baicalin exerts its effects through defined molecular targets:

    • KEAP1-NRF2/HO-1 Axis: Baicalin disrupts KEAP1-mediated degradation of NRF2, enabling NRF2 nuclear translocation and upregulation of antioxidant and cytoprotective genes, including HO-1 (mechanistic summary).
    • TGF-β1/p-Smad3 Pathway: In breast cancer metastasis models, Baicalin suppresses TGF-β1-induced phosphorylation of Smad3, inhibiting epithelial-mesenchymal transition (EMT) and metastatic spread (mechanistic leverage).
    • Neuroplasticity Modulation: In adult mouse visual cortex, Baicalin at 10 mg/kg reactivates ocular dominance plasticity, reduces GABA-synthesizing enzyme (GAD65/67) expression, and diminishes perineuronal nets, thereby decreasing cortical inhibition (Yin et al., 2026).
    • Ferritinophagy and Macrophage Immunity: Baicalin promotes ferritinophagy, increasing ferroptosis sensitivity in NSCLC and modulates tumor-associated macrophage activity, enhancing chemotherapy efficacy.

    Evidence & Benchmarks

    • Baicalin at 10 mg/kg restores ocular dominance plasticity and normalizes visual acuity in adult amblyopic mice, while 5 mg/kg or crude Scutellaria extract does not (Yin et al., 2026).
    • Baicalin reduces GAD65/67 and perineuronal net expression in V1, correlating with decreased inhibition and increased plasticity in adult cortex (Yin et al., 2026).
    • In NSCLC models, Baicalin enhances cisplatin sensitivity by promoting ferritinophagy and modulating macrophage immunity (translational studies).
    • Baicalin inhibits TGF-β1/p-Smad3 signaling, suppressing breast cancer metastasis in preclinical models (mechanistic analysis).
    • Supplied by APExBIO, Baicalin is ≥98% pure (HPLC/NMR-verified), soluble in DMSO at ≥21.8 mg/mL, and stable as a solid at −20°C (product details).

    Applications, Limits & Misconceptions

    Baicalin is used in both in vitro and in vivo research for cancer biology, neuroplasticity, and immunology. Its defined purity and solubility profile make it suitable for controlled mechanistic studies. The following section clarifies boundaries and corrects common misconceptions.

    Common Pitfalls or Misconceptions

    • Baicalin is not effective as a crude water or ethanol extract—purified compound is required for reproducible outcomes (Yin et al., 2026).
    • Its activity is dose-dependent; sub-therapeutic doses (e.g., 5 mg/kg) may be ineffective in plasticity models.
    • It is insoluble in water and ethanol; improper solvents compromise experimental validity (product page).
    • Baicalin's reversal of cortical inhibition is blocked by GABAA receptor agonists, indicating its effect is not universal across all inhibitory states (Yin et al., 2026).
    • Therapeutic claims beyond preclinical models remain unproven in humans and require further validation.

    Workflow Integration & Parameters

    For research use, Baicalin (APExBIO N1778) is supplied as a powder (≥98% purity, HPLC/NMR-verified). It is soluble in DMSO at concentrations ≥21.8 mg/mL, but insoluble in water and ethanol. For in vivo studies, dosing regimens should replicate published benchmarks (e.g., 10 mg/kg i.p. for neuroplasticity). Solutions in DMSO should be freshly prepared and used promptly to minimize degradation. The solid should be stored at −20°C; APExBIO ships under cold conditions (Blue Ice for small molecules). Analytical purity and batch-to-batch consistency are routinely confirmed by supplier quality controls (Baicalin product page).

    For further mechanistic guidance, the article 'Baicalin: Mechanistic Leverage and Strategic Guidance' provides a broader review of translational strategies. Unlike that piece, this article emphasizes atomic experimental facts and technical parameters for workflow optimization.

    Conclusion & Outlook

    Baicalin, as supplied by APExBIO, is a well-characterized flavone glycoside from Scutellaria baicalensis with validated activity in both cancer and neuroplasticity models. Its ability to modulate redox and cell signaling pathways—KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3—is supported by robust, dose-dependent in vivo and in vitro evidence. Baicalin's translational potential is significant, but boundaries must be respected: its effects are contingent on purity, dose, and correct solvent use, and human efficacy remains to be established. For detailed mechanistic and application guidance, researchers are encouraged to consult both this article and broader reviews (see here for updated solubility and purity data).